Johnson & Johnson ( JNJ) reported that its cancer drug Rybrevant Faspro, combined with immunotherapy and chemotherapy, shrank ...

A retrospective study finds that higher BMI is associated with better survival after head and neck cancer radiotherapy, but muscle and fat distribution reveal a more nuanced picture.

A qualitative study of 14 Brazilian patients found that before starting treatment for lung or head and neck cancer, most knew ...

Beginning survivorship care for head and neck cancer patients earlier is linked to better survival and lower recurrence, ...

A preclinical study reports that cannabidiol selectively impaired viability, migration, invasion, and clonogenic survival of ...

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs i ...

A trial has shown a new triple therapy may help to shrink tumours in patients with difficult-to-treat and aggressive cancers.

Expert and company perspectives on the role of amivantamab in advancing first-line treatment “Patients with recurrent or metastatic head and neck cancer continue to face a poor prognosis, highlighting ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...

Genmab presented clinical updates on petosemtamab, an investigational bispecific antibody, in two major solid tumor types at ...

Please provide your email address to receive an email when new articles are posted on . Patients with head and neck cancer have a higher risk for depression than those with other cancers. Rates of ...